-transparent.png){kind=logo}
The term "effective activator" of plasminogen is proposed, to denote the resultant of activator-antiactivator interaction, and a method for the determination of the level of these activators is described. By adding axcess plasminogen to the euglobulin fraction of plasma the influence of the level of endogenous plasminogen and of the antiplasmin is eliminated. It is shown that the level of fibrinogen has very little bearing on the results. An effective activator unit is defined as equal to 1 CTA unit of urokinase activity on a fibrinogen-plasminogen substrate.
Related Publications
R Margalit, and
E Gidron, and
Y Shalitin
January 1974,
Folia haematologica (Leipzig, Germany : 1928),
R Margalit, and
E Gidron, and
Y Shalitin
January 1967,
Haematologica,
R Margalit, and
E Gidron, and
Y Shalitin
August 1977,
Biulleten' eksperimental'noi biologii i meditsiny,
R Margalit, and
E Gidron, and
Y Shalitin
January 1972,
Folia haematologica (Leipzig, Germany : 1928),
R Margalit, and
E Gidron, and
Y Shalitin
January 1980,
Annals of clinical biochemistry,
R Margalit, and
E Gidron, and
Y Shalitin
July 1968,
Thrombosis et diathesis haemorrhagica,
R Margalit, and
E Gidron, and
Y Shalitin
January 1995,
Molekuliarnaia biologiia,
R Margalit, and
E Gidron, and
Y Shalitin
April 1993,
Bollettino chimico farmaceutico,
R Margalit, and
E Gidron, and
Y Shalitin
March 1990,
Thrombosis research,
R Margalit, and
E Gidron, and
Y Shalitin
January 1977,
Acta clinica Belgica,
